<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang R</submitter><funding>National Key Research and Development Program</funding><funding>National Natural Science Foundation of China</funding><funding>Capital's Funds for Health Improvement and Research of Beijing</funding><pagination>2685-2693</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12423017</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>42(8)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To investigate if trophectoderm (TE) biopsy on preimplantation genetic testing (PGT) increases the risk of obstetrical and infant outcomes after frozen single blastocyst transfer cycles.&lt;h4>Methods&lt;/h4>This retrospective cohort study included all frozen single blastocyst transfer cycles conducted between January 2012 and December 2017 at Peking University Third Hospital. A total of 1492 patients in the PGT group and 600 patients in the non-PGT group were analyzed. The primary outcomes were clinical pregnancy rate, live birth rate, and early motor development milestones. Secondary outcomes included miscarriage, obstetric complications, and infant outcomes.&lt;h4>Results&lt;/h4>The PGT group had younger parental ages and higher antral follicle counts, whereas the non-PGT group had </pubmed_abstract><journal>Journal of assisted reproduction and genetics</journal><pubmed_title>The obstetrical and infant outcomes of trophectoderm biopsy on preimplantation genetic testing embryos after frozen single embryo transfer cycles.</pubmed_title><pmcid>PMC12423017</pmcid><funding_grant_id>82171632</funding_grant_id><funding_grant_id>2022YFC2702905</funding_grant_id><funding_grant_id>2021YFC2700605</funding_grant_id><funding_grant_id>2024-2-40911</funding_grant_id><funding_grant_id>2024YFC2706702</funding_grant_id><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Liu P</pubmed_authors><pubmed_authors>Zhang N</pubmed_authors><pubmed_authors>Yang R</pubmed_authors><pubmed_authors>Tian T</pubmed_authors><pubmed_authors>Han Z</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Qiao J</pubmed_authors><pubmed_authors>Gao C</pubmed_authors></additional><is_claimable>false</is_claimable><name>The obstetrical and infant outcomes of trophectoderm biopsy on preimplantation genetic testing embryos after frozen single embryo transfer cycles.</name><description>&lt;h4>Purpose&lt;/h4>To investigate if trophectoderm (TE) biopsy on preimplantation genetic testing (PGT) increases the risk of obstetrical and infant outcomes after frozen single blastocyst transfer cycles.&lt;h4>Methods&lt;/h4>This retrospective cohort study included all frozen single blastocyst transfer cycles conducted between January 2012 and December 2017 at Peking University Third Hospital. A total of 1492 patients in the PGT group and 600 patients in the non-PGT group were analyzed. The primary outcomes were clinical pregnancy rate, live birth rate, and early motor development milestones. Secondary outcomes included miscarriage, obstetric complications, and infant outcomes.&lt;h4>Results&lt;/h4>The PGT group had younger parental ages and higher antral follicle counts, whereas the non-PGT group had </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-01T23:29:33.761Z</modification><creation>2026-05-23T03:08:12.501Z</creation></dates><accession>S-EPMC12423017</accession><cross_references><pubmed>40632424</pubmed><doi>10.1007/s10815-025-03512-7</doi></cross_references></HashMap>